India's bioeconomy is set to hit $300 billion by 2030, driving agricultural resilience and global competitiveness, says NITI Aayog.

Manufacturing line has now been validated for human-use production in support of expected Q1 2026 market launch. Pivot will be First Two-Part Tubeless Patch Pump: Pivot, a 3 milliliter removable patch ...

Gut microbiome tests are everywhere. Should you get one? - At-home tests of the gut's microbiome are trending, but doctors ...

The latest blow came from the U.S. Health Secretary, placing even more pressure on Kenvue stock, which has already lost 40% of its value in the last six months. Robert F. Kennedy Jr. recently made ...